Strata Critical Medical: End-to-End Organ Transplantation Logistics with Doubling Potential!
Reading Time: 2 minutes
Strata Critical Medical (SRTA) underwent a strategic shift in 2025 with the sale of its passenger business and the name change to Blade Air Mobility (BLDE) to fully focus on the medical market. Today, the company is already considered in the USA as the only end-to-end platform in the field of organ transplantation logistics. This prompted B. Riley's experts to announce a target price of $8 (Buy) on March 25, which corresponds to an upside potential of around 85%. The acquisition of Keystone Perfusion was crucial in expanding the logistics business...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

